743.76 - 757.57
479.80 - 796.25
8.25M / 11.73M (Avg.)
27.40 | 27.58
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
11.71%
Revenue growth 1.25-1.5x BIDU's 9.35%. Bruce Berkowitz would check if differentiation or pricing power justifies outperformance.
15.61%
Gross profit growth 1.25-1.5x BIDU's 13.08%. Bruce Berkowitz would see if strategic sourcing or brand premium explains outperformance.
22.02%
EBIT growth above 1.5x BIDU's 4.62%. David Dodd would confirm if core operations or niche positioning yield superior profitability.
22.02%
Operating income growth above 1.5x BIDU's 4.62%. David Dodd would confirm if consistent cost or pricing advantages drive this outperformance.
36.42%
Positive net income growth while BIDU is negative. John Neff might see a big relative performance advantage.
37.10%
Positive EPS growth while BIDU is negative. John Neff might see a significant comparative advantage in per-share earnings dynamics.
35.45%
Positive diluted EPS growth while BIDU is negative. John Neff might view this as a strong relative advantage in controlling dilution.
-0.73%
Share reduction while BIDU is at 0.21%. Joel Greenblatt would see if the company has a better buyback policy than the competitor.
0.62%
Slight or no buyback while BIDU is reducing diluted shares. John Neff might consider the competitor’s approach more shareholder-friendly.
No Data
No Data available this quarter, please select a different quarter.
23.65%
OCF growth under 50% of BIDU's 82.05%. Michael Burry might suspect questionable revenue recognition or rising costs.
55.02%
FCF growth 50-75% of BIDU's 74.39%. Martin Whitman would see if structural disadvantages exist in generating free cash.
1609.29%
10Y revenue/share CAGR above 1.5x BIDU's 349.47%. David Dodd would confirm if management’s strategic vision consistently outperforms the competitor.
175.94%
5Y revenue/share CAGR above 1.5x BIDU's 30.77%. David Dodd would look for consistent product or market expansions fueling outperformance.
91.82%
3Y revenue/share CAGR above 1.5x BIDU's 28.29%. David Dodd would confirm if there's an emerging competitive moat driving recent gains.
1168.00%
10Y OCF/share CAGR above 1.5x BIDU's 231.02%. David Dodd would check if a superior product mix or cost edge drives this outperformance.
213.53%
OCF/share CAGR of 213.53% while BIDU is zero. Bruce Berkowitz would see if modest momentum can translate into a bigger competitive lead.
399.99%
3Y OCF/share CAGR above 1.5x BIDU's 27.33%. David Dodd would confirm if the firm is quickly gaining an operational edge over the competitor.
2178.64%
Net income/share CAGR above 1.5x BIDU's 96.64% over 10 years. David Dodd would confirm if brand, IP, or scale secure this persistent advantage.
74.03%
Positive 5Y CAGR while BIDU is negative. John Neff might view this as a strong mid-term relative advantage.
68.48%
3Y net income/share CAGR above 1.5x BIDU's 42.77%. David Dodd would confirm the company’s short-term strategies outmatch the competitor significantly.
951.13%
10Y equity/share CAGR 1.25-1.5x BIDU's 652.59%. Bruce Berkowitz would see if strong ROE or conservative payout policy fosters faster book value growth.
92.65%
5Y equity/share CAGR above 1.5x BIDU's 57.63%. David Dodd might see stronger earnings retention or fewer asset impairments fueling growth.
35.94%
3Y equity/share CAGR at 75-90% of BIDU's 40.48%. Bill Ackman pushes for margin or operational changes to match the competitor’s pace.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
13.28%
AR growth well above BIDU's 2.63%. Michael Burry fears inflated revenue or higher default risk in the near future.
No Data
No Data available this quarter, please select a different quarter.
12.03%
Asset growth above 1.5x BIDU's 1.33%. David Dodd checks if M&A or new capacity expansions are value-accretive vs. competitor's approach.
8.20%
BV/share growth above 1.5x BIDU's 2.16%. David Dodd confirms if consistent profit retention or fewer write-downs yield faster equity creation.
31.34%
We have some new debt while BIDU reduces theirs. John Neff sees the competitor as more cautious unless our expansions pay off strongly.
-0.39%
Our R&D shrinks while BIDU invests at 17.67%. Joel Greenblatt checks if we risk falling behind a competitor’s new product pipeline.
23.43%
SG&A growth well above BIDU's 16.16%. Michael Burry sees potential margin erosion unless it translates into higher sales or brand equity.